RecruitingNCT06904820
Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
Sponsor
University Hospital, Limoges
Enrollment
2,300 participants
Start Date
Jun 5, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The "Scanvir" concept aims to achieve barriers to HCV screening and treating of marginalized patients. The concept is applicable to other various populations and territories and should effectively improve HCV patient's health outcomes. The main objective of the SCANVIR project was to evaluate the feasibility, acceptability and reproducibility of a "test, treat and cure" strategy for PWIDs and vulnerable populations during dedicated days in addiction care centers.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Adult 18 and over
- Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector
- Patient not opposed to research
Exclusion Criteria2
- Age under 18
- Patient opposed to research
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06904820